High-flow nasal cannula therapy for children
and adolescents with obstructive sleep apnoea:
abridged secondary publication
KCC Chan1, CT Au1,2, KL Kwok3, AM Li1
1 Department of Paediatrics, Faculty of Medicine, The Chinese University
of Hong Kong, Hong Kong SAR, China
2 Translational Medicine, Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada
3 Department of Paediatrics, Kwong Wah Hospital, Hong Kong SAR, China
- The efficacies of high-flow nasal cannula (HFNC) and continuous positive airway pressure (CPAP) therapies are similar in reducing disease severity among children and adolescents with moderate-to-severe obstructive sleep apnoea.
- Self-reported adherence is higher with CPAP therapy than with HFNC therapy.
- Both HFNC and CPAP therapies significantly improved disease-specific quality-of-life scores, but not behavioural measures.